Major funding unlocks research pathways for innovative antiviral treatment against influenza
Posted: 1 March 2024 The University of Melbourne at the Doherty Institute has secured $3.1 million of funding from the Novo Nordisk Foundation to develop a novel antiviral drug to counter influenza. This could be a game changer…
New Guidance Document to Bolster AMR Surveillance in the Western Pacific
Posted: 1 March 2024 In the ongoing battle against the threat of antimicrobial resistance (AMR), the WHO Collaborating Centre for Antimicrobial Resistance at the Doherty Institute, in collaboration with the WHO Regional Office for the Western Pacific (WPRO),…
New insight into gene uncovers its link to incurable birth defect
Posted: 1 March 2024 Researchers have unravelled how mutations in a gene can lead to an incurable neurodevelopmental disorder that causes abnormal brain development in newborns and infants. The study, published in the journal eLife, is the first to…
BioMelbourne Network signs MOU with leading state industry associations
Posted: 28 February 2024 BioMelbourne Network is delighted to announce a Memorandum of Understanding and partnership with leading state industry associations BioNSW and Life Sciences Queensland Ltd (LSQ). The alliance acknowledges the shared ideals and opportunities regarding events,…
Imbio Secures Research Agreement with U.S. Dept of Veteran Affairs
Posted: 28 February 2024 Respiratory imaging technology company 4DMedical Limited (ASX:4DX, “4DMedical”, or the “Company”) today announces the signing of a research agreement with the U.S. Department of Veterans Affairs (VA). VA research agreement 4DMedical’s wholly owned subsidiary,…
Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics
Posted: 28 February 2024 Telix today announces it has entered into an agreement to acquire IsoTherapeutics Group, LLC (IsoTherapeutics), a specialty radiopharmaceutical development and bioconjugation firm, based in Angleton, Texas. Founded in 2005, IsoTherapeutics is a privately held,…
DATA COLLECTION COMPLETE FOR FIRST INTERIM ANALYSIS IN ACTION3 PHASE 3 CLINICAL TRIAL FOR FSGS KIDNEY DISEASE
Posted: 27 February 2024 Dimerix Limited (ASX: DXB, “Dimerix”), is pleased to confirm that data from the first 72 patients randomised in the ACTION3 Phase 3 trial of DMX-200 in patients with focal segmental glomerulosclerosis (FSGS) has successfully…
Clearer and faster: 5-minute MRI on the horizon
Posted: 27 February 2024 A 5-minute full-body MRI scan could soon become a reality with the help of a promising new AI method developed by Monash University engineers. In a study published in Computers in Biology and Medicine, researchers have…
MTPConnect’s TTRA Program Delivering Strong Health and Economic Impact at Halfway Mark
Posted: 27 February 2024 A new report published today shows MTPConnect’s Targeted Translation Research Accelerator (TTRA) program for diabetes and cardiovascular disease is already delivering benefits and novel health solutions for Australian patients and the health sector – just over halfway…
INOVIQ DETECTS 19% MORE BREAST CANCERS THAN LEADING TEST
Posted: 27 February 2024 INOVIQ Limited (ASX:IIQ or INOVIQ) is excited to announce the successful completion of its breast cancer study. In a 2023 clinical validation study (n=483), INOVIQ’s SubB2M/CA15-3 test detected over 80% of breast cancers across…
Nanodiamonds could hold key to cool clothing
Posted: 21 February 2024 Researchers from RMIT University are using nanodiamonds to create smart textiles that can cool people down faster. The study found fabric made from cotton coated with nanodiamonds, using a method called electrospinning, showed a…
Ultrasound jolts lazy sperm to life, offering hope in male infertility
Posted: 21 February 2024 Exposing “lazy” human sperm to ultrasound can increase their swimming activity more than three-fold and improve the success rate of assisted reproduction, a new study has found. Engineering researchers at Monash University have shown…
